ArticleScience China. Life sciences2026

A novel pathologic scoring system for predicting postoperative recurrence in BCLC stage 0-A hepatocellular carcinoma patients: a nationwide multicenter study.

Feng Xia et al.PubMed ↗Publisher ↗

No numbers read from the abstract.